Skip to main content
Premium Trial:

Request an Annual Quote

Maverix Biomics Raises $6M in Series A Round

NEW YORK (GenomeWeb News) – Bioinformatics firm Maverix Biomics today announced it raised $6 million in a Series A financing round to support the continued commercialization of its recently launched data analysis platform.

The financing was led by Asset Management Ventures and individual investors Andreas Bechtolsheim and Andrew Yang. In conjunction with the financing, Yang and Louis Lange, a general partner at Asset Management, have joined Maverix's board.

The company launched its flagship product, the Maverix Analytic Platform, in November for simplifying complex big data analytics. Today's funding will be used to increase adoption of the system. According to Maverix, the platform "integrates the management, exploration, and visualization of genomic data into one easy-to-use system."

Shortly after the system's launch, Maverix said it inked a deal with Qiagen to integrate the platform with Qiagen's Ingenuity iReport biological data interpretation solution.